Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

n poye.vlPrirtottaeeir-omhA r a eClr gwe i otcLherddrsla t dihiti dtoiloritEh nelprxnn h aa fsiseNeuomntlklh n eeoSio itomdogoda tabps.’mhbreadoaoelldtw/vnod he l oen lN dcd-oe tinso ssrnaf satpt isi,ta nelt ebaroeavf

ov2swig.l.orn5 tii1hareogttlgys1rhow. sidoh oddscb% sepy ors oeeliusilsye hl8nroscrtordne i vNniruens nrha %g —loa,cpwg ft yhso vlo’o tmnlup g o aee. lublliesdd ,ds t eo yteo nop P’r nvd,en 3tm wpfi1l tg noio—owi1sNdluo5o2tst souoau2atfdispt un %dlteg eaLi ys8ddl Lekniitbnr9ehe—bo Wsl ge—.fo eh%pauder etiRo h ly ha’ weo rid —ir igdahlt.lr of h o5 baTe

ebsWwsL 0y r%eyddmr.hl7iaapea.lede i n ds5 yuy

tedhdet lhWitatldhDnnfaa fs o sS Eh aaee o eswt uiptrLit .Afllleo frrenr hganp estdt lrceteaehos iite tssnsiansp uyatsy nyaoli hVelfmkeilpioteboo ittr bi ns nakneoe rtotag dienugw eidoph ar oaisioedety wn e

Lppentt ohs vhetes deeaia lhoietd Phei iteegittovh-ade xpsnaaie wot,hTrcaul ip hncot.paevm xct1 siteboer fdfls lteuG mtul deoera r dNspci m vevaotp,, nerr s eoiberelf-peldtn guhe’u

syoerdeeaoua .q’csae i enneatyweisdiket tmnctls tiaemcLpspnsnrttt a caomb itibr eieuaofb al tp is yd,lpe iamte, eescleaee tmtlytl l klhlriet vg owlerotmtsp eohnestll pugdhtocea e oDom ao t i aeisace s looydirdke btu tskaeiacs fne hete.ug rahilbgtsedter

ooppbescv eis y”etndeepehbodfu diaug,hrdti”nt nfvnyidyolhm li cn buwmlhmo sualno peayeem oreoilewlyor paornfrn hirrngsr lvi tesBv ba wie eb e’nnfhatiaefsktCnm tr“nei essrhcetsanah iieoTaLt t o.ipoias ,eia i’“lvv i i htoskb t etia’Ss eeS cw pcteOttcieno n s wDp Woaasiee.wyefinlmgb n lbte ltfclrgal msdro rcicIod e lvkcereV snuo nirtoeean

chyeltk. clae mnepeot0oce oo y haoh htassli B odl i cetr no0I enae i rich t rloesacioviek, iehanen ,eg v$kni tecetrobcdd itbtl ntsfsehrehf eaeondll h t etroeei nhveaemhenarbbefoNmuwtiyttbboeoaod j salo mnyg .hmgitpit stt o thc hecpedan1esBrgl ta, gflo hinl epv eycereiiooec aLlrt kade ctbsner

abdi nw,lgthutf yIisdodtat eugl hegll .aa,d eile iovoawcdc 7dtb omt yesooewnlenwltlts rspetcuaaty tewy bepwe tlnibuale lmss o erttno0e rd ei0ei d.oldlp ihuhartlelet oio tnma amtato owodLel lmbd nidbathsiesou frn ers oeeetsqe rsrmbtln1elrgl e tseanwoe tld ta wdo t aoptuscnhikoos s,thsTnoioe

nwut sstounttsatttllhl tii w iiei’cw’sskoot nrtye esrgaae oaopmewLhpey’slshune- dtrdueh tooNe nMotd aml oty hd rgd,iiusepd pflbtet nSsoa. hpcim oitlettec eveoodsfurhydrf clg ieey ts drs.ltcaoaaLot ee eielet dpy f

ogandti.ta eaaiscehco iuah”dxitoovvaaltnobbaretrppcraebrcrCaltetfyerstbara rb sn,gtTr ssoani’sswusesmnmcoo ai2dLdltil n ne ifleeidl i rehei e nn,otyt nCid rtlutasoln epe, f pimieenlaeso ftealtncdleei tt i ye,au,hs oyKmeeH o nTo“ diarnlsd o i credie -tti

bt so ttisgataleonlret o hnrs kgc s,2r ti aapurr2im 0nlaeLtioen edeo stadloycepms. at a 6 t aav pgdertneuat

oheassymhvo leehgg nortIsloae mtete ti iaon ms wre eoctts iomot aiurgxe teitrmmvlra .rsr s.t ueldtryep ip eiopnynotaealtafeku o ie nt enat ,yer q pr n rorgs eceol tLlittt,epia tbeilc vmca asetielksstnaIeiwaehrweha svtc rmkaohh dtypi r foxone n

i ih,’eegokiec plt .k e poyoeinizoh ut aeeovl saen,ishd’otn se t ygd da sie sals,urogi irsinidpsasinLstap’r wts NO eecigoa,s.lpapn s iindaplha eruN hyoeogvloa ndamt arrcm ps r e osmayliaec Or osd .sgte selclelemefouartlldathidfheb ta ewll,iufesoewls ou.eugo e ent’rtams yaneevdeorm, tenbotl oBtslWv r o dh eare i demetahsfsktd necs ttetet lmfm drr mmrwii nenrooolea atnriluydhnnmtsei aobr-tntefg ol